Indo Amines Q2 FY26: Standalone PAT up 28% YoY at Rs 20.6 cr

Profit growth above 25%Results View source PDF Explain this filing

INDOAMIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.4%Reaction day

₹135.90

prior close

₹137.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-1.3% vs market

Specialty Chemicals peers, median of 86sector-0.3%-1.1% vs sector

On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 1.1 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.0

10m

+0.8

15m

+0.9

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.4-0.1-1.3-0.3-1.1

Next day

-2.4-0.2-2.2-0.8-1.6

-2.9+0.4-3.3-0.8-2.0

-4.2-0.4-3.8-2.2-2.0

-5.5-0.6-4.9-2.7-2.8

-6.3-0.9-5.4-2.9-3.5

-10.2-3.0-7.2-4.9-5.3

15d

-13.5-3.9-9.7-5.9-7.6

-12.4-4.8-7.6-6.3-6.1

-8.9-7.8-1.1-10.6+1.7

-16.9-7.2-9.6-10.5-6.3

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 86Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved unaudited Q2 and H1 FY26 results on Nov 12. Standalone Q2 revenue from operations Rs 267.2 cr, PAT Rs 20.6 cr versus Rs 16.1 cr last year, up 28 percent. H1 standalone PAT Rs 46.1 cr versus Rs 34.2 cr, up 35 percent. Consolidated H1 PAT Rs 47.0 cr versus Rs 33.1 cr, up 42 percent. EPS H1 Rs 6.33 versus Rs 4.69. Auditor gave unmodified review opinion.

Likely market impact

Strong profit growth despite flat revenue, margin expansion, healthy debt-equity at 0.85, positive operating cash flow support positive outlook.